The diverse neurological manifestations of liver disease pose a diagnostic challenge for
modern hepatologists with magnetic resonance (MR) techniques representing a highly profitable avenue
to investigate structural and functional aspects of brain dysfunction. The commonest, but not sole
neurological manifestation of liver disease, hepatic encephalopathy (HE), is a sequel of both acute and
chronic liver failure, ranging from cognitive impairment, only detectable on psychometric evaluation
through to confusion, coma and death from cerebral edema. While there is widespread acceptance of its
importance, there is little consensus on how best to diagnose and monitor HE. Clinical descriptions,
psychometric testing, electroencephalography (EEG) and lately, imaging techniques, such as magnetic
resonance (MR) imaging, MR spectroscopy and positron emission tomography (PET) all have their
proponents, but most putatively, diagnostic paradigms remain the preserve of research establishments
with an interest in HE. Of note, modern clinical MRI scanners with multinuclear MR spectroscopy
capabilities and brain mapping software can objectively demonstrate structural and functional cellular
changes (such as brain size and astrocyte swelling) using volumetric MRI, magnetization transfer MRI,
diffusion-weighted MRI, functional MRI with oxygenation measurements and in vivo 1H and 31P MR
spectroscopy, with the option of performing many sequences at a single session to maximize
information gathering and cohort characterization. These techniques are also transferable to characterize
non-HE cases of neurological dysfunction in liver disease, such as primary biliary cirrhosis, the
neuropsychiatric sequela of non-cirrhotic chronic hepatitis C infection and metal deposition disorders,
such as Wilson’s disease and hemochromatosis. This chapter describes the relative merits of these MR
techniques and provides guidance on the directions for future research and translational into clinical
practice.
Keywords: Magnetic resonance; Functional MRI; Hepatic encephalopathy; MR spectroscopy; Positron
emission tomography (PET).